Two Sigma Investments’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-405
Closed -$15.2K 4052
2025
Q3
$15.2K Buy
+405
New +$23.3K ﹤0.01% 3610
2025
Q2
Sell
-57
Closed -$8.13K 3158
2025
Q1
$8.13K Buy
57
+1
+2% +$233 ﹤0.01% 3138
2024
Q4
$19.4K Buy
56
+17
+44% +$2.88K ﹤0.01% 3113
2024
Q3
$7.2K Buy
+39
New +$6.2K ﹤0.01% 3056
2023
Q4
Sell
-11
Closed -$9.74K 3119
2023
Q3
$9.74K Sell
11
-2
-15% -$2.57K ﹤0.01% 2900
2023
Q2
$19.3K Sell
13
-19
-59% -$27.8K ﹤0.01% 2909
2023
Q1
$48.7K Buy
32
+22
+220% +$41.4K ﹤0.01% 2760
2022
Q4
$11K Sell
10
-4
-29% -$7.29K ﹤0.01% 2726
2022
Q3
$32K Buy
+14
New +$60.6K ﹤0.01% 2349
2022
Q2
Sell
-7
Closed -$40K 2458
2022
Q1
$40K Sell
7
-11
-61% -$65.6K ﹤0.01% 2503
2021
Q4
$134K Buy
+18
New +$205K ﹤0.01% 4007
2021
Q3
Sell
-8
Closed -$161K 4190
2021
Q2
$161K Buy
+8
New +$92.1K ﹤0.01% 3836

Other funds holding AEMD

Two Sigma Investments's AEMD Position: Q4 2025 in Review

Two Sigma Investments sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 405 shares — an estimated $15.2K sold.

Two Sigma Investments first reported a position in AEMD in Q2 2021 and held it in 12 quarters. The position peaked at $161K in Q2 2021. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

  • Two Sigma Investments reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 405 Aethlon Medical shares in Q4 2025, an estimated $15.2K.
  • Two Sigma Investments first reported a position in Aethlon Medical in Q2 2021 and held it in 12 quarters.
  • Two Sigma Investments's Aethlon Medical position peaked at $161K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.